As of 2025-09-16, the EV/EBITDA ratio of Vir Biotechnology Inc (VIR) is -0.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIR's latest enterprise value is 454.32 mil USD. VIR's TTM EBITDA according to its financial statements is -587.51 mil USD. Dividing these 2 quantities gives us the above VIR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 15.8x | 14.6x |
| Forward P/E multiples | 15.8x - 18.8x | 17.3x |
| Fair Price | (65.30) - (65.22) | (65.83) |
| Upside | -1463.3% - -1461.5% | -1474.3% |
| Date | EV/EBITDA |
| 2025-09-12 | -0.82 |
| 2025-09-11 | -0.88 |
| 2025-09-10 | -0.85 |
| 2025-09-09 | -0.88 |
| 2025-09-08 | -0.87 |
| 2025-09-05 | -0.89 |
| 2025-09-04 | -0.86 |
| 2025-09-03 | -0.94 |
| 2025-09-02 | -0.82 |
| 2025-08-29 | -0.81 |
| 2025-08-28 | -0.83 |
| 2025-08-27 | -0.88 |
| 2025-08-26 | -0.69 |
| 2025-08-25 | -0.68 |
| 2025-08-22 | -0.72 |
| 2025-08-21 | -0.68 |
| 2025-08-20 | -0.67 |
| 2025-08-19 | -0.67 |
| 2025-08-18 | -0.70 |
| 2025-08-15 | -0.71 |
| 2025-08-14 | -0.69 |
| 2025-08-13 | -0.72 |
| 2025-08-12 | -0.67 |
| 2025-08-11 | -0.65 |
| 2025-08-08 | -0.66 |
| 2025-08-07 | -0.67 |
| 2025-08-06 | -0.84 |
| 2025-08-05 | -0.85 |
| 2025-08-04 | -0.85 |
| 2025-08-01 | -0.83 |
| 2025-07-31 | -0.84 |
| 2025-07-30 | -0.88 |
| 2025-07-29 | -0.88 |
| 2025-07-28 | -0.94 |
| 2025-07-25 | -0.98 |
| 2025-07-24 | -1.00 |
| 2025-07-23 | -1.02 |
| 2025-07-22 | -1.00 |
| 2025-07-21 | -0.95 |
| 2025-07-18 | -0.92 |
| 2025-07-17 | -0.94 |
| 2025-07-16 | -0.92 |
| 2025-07-15 | -0.89 |
| 2025-07-14 | -0.94 |
| 2025-07-11 | -0.98 |
| 2025-07-10 | -1.04 |
| 2025-07-09 | -1.04 |
| 2025-07-08 | -0.89 |
| 2025-07-07 | -0.89 |
| 2025-07-03 | -0.92 |